Understanding the Risk of Using Medications for Attention Deficit Hyperactivity Disorder with Respect to Physical Growth and Cardiovascular Function

VITIELLO, BENEDETTO
2008-01-01

2008
17
2
459
474
Adolescent; Adrenergic Uptake Inhibitors; Appetite; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Height; Central Nervous System Stimulants; Child; Child, Preschool; Controlled Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography; Heart Rate; Humans; Long-Term Care; Methylphenidate; Propylamines; Risk Factors; Psychiatry and Mental Health; Pediatrics, Perinatology and Child Health
Vitiello, Benedetto
File in questo prodotto:
File Dimensione Formato  
vitiello.understanding stimulant safety.08.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 164.94 kB
Formato Adobe PDF
164.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1646336
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 94
  • ???jsp.display-item.citation.isi??? 75
social impact